BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10629082)

  • 1. lacZ-neoR transfected glioma cells in syngeneic rats: growth pattern and characterization of the host immune response against cells transplanted inside and outside the CNS.
    Visted T; Thorsen J; Thorsen F; Read TA; Ulvestad E; Engebraaten O; Sorensen D; Ylä-Herttuala S; Tyynela K; Rucklidge G; Edvardsen K; Bjerkvig R; Lund-Johansen M
    Int J Cancer; 2000 Jan; 85(2):228-35. PubMed ID: 10629082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfection of glioma cells with the neural-cell adhesion molecule NCAM: effect on glioma-cell invasion and growth in vivo.
    Edvardsen K; Pedersen PH; Bjerkvig R; Hermann GG; Zeuthen J; Laerum OD; Walsh FS; Bock E
    Int J Cancer; 1994 Jul; 58(1):116-22. PubMed ID: 8014007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting the lacZ reporter gene for quantitative analysis of disseminated tumor growth within the brain: use of the lacZ gene product as a tumor antigen, for evaluation of antigenic modulation, and to facilitate image analysis of tumor growth in situ.
    Lampson LA; Lampson MA; Dunne AD
    Cancer Res; 1993 Jan; 53(1):176-82. PubMed ID: 8416743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new rat brain-glioma model].
    Xing B; Ren Z; Su C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):241-5. PubMed ID: 11367685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lac-z reporter gene: a tool for in vitro studies of malignant glioma cell invasion.
    Garcia-Cabrera I; Edvardsen K; Tysnes BB; Read T; Bjerkvig R
    Invasion Metastasis; 1996; 16(3):107-15. PubMed ID: 9186546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
    Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
    Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
    Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migratory patterns of lac-z transfected human glioma cells in the rat brain.
    Pedersen PH; Edvardsen K; Garcia-Cabrera I; Mahesparan R; Thorsen J; Mathisen B; Rosenblum ML; Bjerkvig R
    Int J Cancer; 1995 Sep; 62(6):767-71. PubMed ID: 7558428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunology of brain tumors: immunological situation of the brain].
    Tanaka R; Sobue H
    No To Shinkei; 1983 May; 35(5):451-9. PubMed ID: 6354218
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
    Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
    Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.
    Paul DB; Barth RF; Yang W; Shen GH; Kim J; Triozzi PL
    Gene Ther; 2000 Jun; 7(12):993-9. PubMed ID: 10871746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of tumor immunogenicity of rat glioma cells by s-Myc expression: eradication of rat gliomas in vivo.
    Asai A; Miyagi Y; Hashimoto H; Lee SH; Mishima K; Sugiyama A; Tanaka H; Mochizuki T; Yasuda T; Kuchino Y
    Cell Growth Differ; 1994 Nov; 5(11):1153-8. PubMed ID: 7848917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic sensitization to tumor-associated antigens during the growth of gliomas of the brain (experimental study)].
    Novichenko NL; Romodanov AP; Zhmareva EN; Gorovoĭ AI
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (2):9-13. PubMed ID: 6741378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The humoral antibody response of rats immunized with chemically modified syngeneic brain cells and glioma cells.
    Stavrou D; Hultén M; Anzil AP; Bilzer T
    Int J Cancer; 1980 Nov; 26(5):629-37. PubMed ID: 7239719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
    Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.